Evidence map›Paper›PMID 35458106›Full record

Trial reportNutrients2022

A Comparison of the Low-FODMAPs Diet and a Tritordeum-Based Diet on the Gastrointestinal Symptom Profile of Patients Suffering from Irritable Bowel Syndrome-Diarrhea Variant (IBS-D): A Randomized Controlled Trial.

Francesco Russo, Giuseppe Riezzo, Antonella Orlando, Michele Linsalata, Benedetta D'Attoma, Laura Prospero, Antonia Ignazzi, Gianluigi Giannelli

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06166563 (Effects of Indoor Activity on the Integrity and Function of the Intestinal Barrier of Patients With Fibromyalgia and Irritable Bowel Syndrome), which is not on this map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06166563 nacompletednot on this mapstarted 2023, after this paper: background citation

Effects of Indoor Activity on the Integrity and Function of the Intestinal Barrier of Patients With Fibromyalgia and Irritable Bowel Syndrome

TypeinterventionalSponsorAzienda Ospedaliera Specializzata in Gastroenterologia Saverio de BellisRan2023 to 2025Enrolled165ConditionsFibromyalgia, Irritable Bowel SyndromeArmsExercise Program
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Francesco RussoFunctional Gastrointestinal Disorders Research Unit, National Institute of Gastroenterology "S. de Bellis" Research Hospital, 70013 Castellana Grotte, BA, Italy.ORCID 0000-0003-0538-6072
Giuseppe RiezzoFunctional Gastrointestinal Disorders Research Unit, National Institute of Gastroenterology "S. de Bellis" Research Hospital, 70013 Castellana Grotte, BA, Italy.
Antonella OrlandoFunctional Gastrointestinal Disorders Research Unit, National Institute of Gastroenterology "S. de Bellis" Research Hospital, 70013 Castellana Grotte, BA, Italy.ORCID 0000-0001-8255-4776
Michele LinsalataFunctional Gastrointestinal Disorders Research Unit, National Institute of Gastroenterology "S. de Bellis" Research Hospital, 70013 Castellana Grotte, BA, Italy.ORCID 0000-0001-7350-2544
Benedetta D'AttomaFunctional Gastrointestinal Disorders Research Unit, National Institute of Gastroenterology "S. de Bellis" Research Hospital, 70013 Castellana Grotte, BA, Italy.
Laura ProsperoFunctional Gastrointestinal Disorders Research Unit, National Institute of Gastroenterology "S. de Bellis" Research Hospital, 70013 Castellana Grotte, BA, Italy.
Antonia IgnazziFunctional Gastrointestinal Disorders Research Unit, National Institute of Gastroenterology "S. de Bellis" Research Hospital, 70013 Castellana Grotte, BA, Italy.
Gianluigi GiannelliScientific Direction, National Institute of Gastroenterology "S. de Bellis" Research Hospital, 70013 Castellana Grotte, BA, Italy.

Funding

Italian Ministry of Health RC 2020-2021, Prog. N° 16 (DDG n. 700/2020)
6 · The paper itself

Abstract

The dietary approach low in oligosaccharides, disaccharides, monosaccharides, and fermentable polyols (FODMAPs-LFD) is a good strategy for treating irritable bowel syndrome (IBS). Beyond the LFD, other dietary approaches with beneficial effects may be hypothesized. Among them, consumption of Tritordeum-based foods (TBD, bread, bakery products, and pasta) in substitution of other cereals seem to achieve promising results. In a randomized controlled trial, we compared the effects of 12 weeks of LFD to TBD in improving the symptom profile of IBS-diarrhea (IBS-D) patients. The two diets equally improved gastrointestinal symptoms and QoL, measured by the IBS Severity Scoring System (IBS-SSS) questionnaire, reducing the total score after four weeks and maintaining this range until the end of treatment (IBS-SSS total score change: −132.1; 95% CI: −74.9 to −189.4 and −130.5; 95% CI: −73.2 to −187.7; p < 0.0001 after LFD and TBD, respectively). The two diets did not modify the micronutrients content when extended for 12 weeks. LFD could be regarded as a first-line dietary approach for IBS-D patients. However, TBD may represent a valid alternative, with high palatability, especially among Italian patients, for whom pasta is considered one of the main assets of dietetic culture, and would be easier to manage in their daily habits.

Indexed as

Irritable Bowel SyndromeDiarrheaDietDiet, Carbohydrate-RestrictedDisaccharidesFermentationHumansMonosaccharidesOligosaccharidesQuality of LifeDisaccharidesMonosaccharidesOligosaccharidesirritable bowel syndromelow-FODMAPs dietsymptom profiletritordeum

Identifiers

PMID35458106
PMCPMC9027989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.